|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2011-7-7
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Response Evaluation Criteria in Solid Tumors (RECIST) may underestimate the efficacy of targeted therapies. In hepatocellular carcinoma (HCC) studies with sunitinib, RECIST-defined response rates are low, although hypodensity on computed tomography (CT) scans occurs more frequently. This exploratory analysis investigated tumor density as a surrogate endpoint of sunitinib activity in a phase II HCC study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:BouattourMohamedM,
pubmed-author:BoucherEvelineE,
pubmed-author:ChengAnn-LiiAL,
pubmed-author:DokmakSafiS,
pubmed-author:DouillardJean-YvesJY,
pubmed-author:DreyerChantalC,
pubmed-author:FaivreSandrineS,
pubmed-author:ImSeock-AhSA,
pubmed-author:KangYoon-KooYK,
pubmed-author:KimJun SJS,
pubmed-author:LanzaloneSilvanaS,
pubmed-author:LechugaMaria JMJ,
pubmed-author:LimHo YHY,
pubmed-author:RaymondEricE,
pubmed-author:SablinMarie-PauleMP,
pubmed-author:SerrateCamilleC,
pubmed-author:VilgrainValérieV,
pubmed-author:XunLinL,
pubmed-author:ZappaMagalyM
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4504-12
|
|
pubmed:meshHeading |
pubmed-meshheading:21531821-Adult,
pubmed-meshheading:21531821-Aged,
pubmed-meshheading:21531821-Antineoplastic Agents,
pubmed-meshheading:21531821-Carcinoma, Hepatocellular,
pubmed-meshheading:21531821-Disease Progression,
pubmed-meshheading:21531821-Female,
pubmed-meshheading:21531821-Humans,
pubmed-meshheading:21531821-Indoles,
pubmed-meshheading:21531821-Liver Neoplasms,
pubmed-meshheading:21531821-Male,
pubmed-meshheading:21531821-Middle Aged,
pubmed-meshheading:21531821-Neoplasm Staging,
pubmed-meshheading:21531821-Perfusion Imaging,
pubmed-meshheading:21531821-Pyrroles,
pubmed-meshheading:21531821-Time Factors,
pubmed-meshheading:21531821-Tomography, X-Ray Computed,
pubmed-meshheading:21531821-Treatment Outcome,
pubmed-meshheading:21531821-Tumor Burden
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinib.
|
|
pubmed:affiliation |
Beaujon University Hospital, Clichy, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
